Free Trial

Franklin Resources Inc. Buys Shares of 839,351 Ardent Health Partners, LLC (NYSE:ARDT)

Ardent Health Partners logo with Medical background

Franklin Resources Inc. purchased a new stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 839,351 shares of the company's stock, valued at approximately $15,839,000. Franklin Resources Inc. owned 0.59% of Ardent Health Partners at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP acquired a new stake in Ardent Health Partners in the third quarter worth about $28,724,000. Point72 Asset Management L.P. bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $27,428,000. Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $22,897,000. Allspring Global Investments Holdings LLC bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $13,119,000. Finally, Soros Fund Management LLC acquired a new position in shares of Ardent Health Partners during the third quarter valued at approximately $4,595,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ARDT shares. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday. Leerink Partners raised their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a research note on Tuesday, November 12th. KeyCorp assumed coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They issued an "overweight" rating and a $24.00 price target on the stock. Bank of America lowered shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Ardent Health Partners currently has an average rating of "Buy" and a consensus price target of $22.00.

Check Out Our Latest Research Report on Ardent Health Partners

Ardent Health Partners Trading Down 0.2 %

Ardent Health Partners stock traded down $0.04 during midday trading on Friday, reaching $16.01. The stock had a trading volume of 487,247 shares, compared to its average volume of 345,148. Ardent Health Partners, LLC has a twelve month low of $14.57 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The firm has a fifty day moving average of $17.24.

Ardent Health Partners Company Profile

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Stories

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines